# Adult Vaccines 2024

Canonical: https://abierto.us/opportunities/75d30124r72943

- Solicitation number: 75D301-24-R-72943
- Notice type: Combined synopsis and solicitation
- Status: Awarded to Vbi Vaccines (Delaware) Inc.
- Department: Department of Health and Human Services
- Agency: Centers for Disease Control and Prevention
- Contracting office: CDC Office of Acquisition Services (75D301)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- First posted: March 25, 2024
- Last posted: March 29, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/57e0e2e32c8b43e7ac61952adb35c4fc/view

## Description

**UPDATE 3/29/2024:** The answers to vendor questions have been uploaded to this posting. The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite-delivery, indefinite-quantity contracts for the purchase of the following adult vaccines, at the estimated quantities listed, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration. See attached RFP for details.

**Hepatitis A Adult Vaccine:** Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 1,000,000 doses Minimum: 100 doses Hepatitis B Adult Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 750,000 doses Minimum: 100 doses Hepatitis A & B Combination Adult Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $1.50 per dose Maximum: 250,000 doses Minimum: 100 doses Herpes Zoster Adult Vaccine: Min. Shelf Life 12 months Fed.

**Excise Tax N/A Maximum:** 500,000 doses Minimum: 100 doses Human Papillomavirus (HPV9)

**Vaccine:** Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 300,000 doses Minimum: 100 doses E-IPV Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 500,000 doses Minimum: 100 doses Measles, Mumps, and Rubella Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $2.25 per dose Maximum: 250,000 doses Minimum: 100 doses Meningococcal Conjugate-Serogroup B Meningococcal Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $1.50 per dose Maximum: 200,000 doses Minimum: 100 doses Mpox Vaccine: Min. Shelf Life 12 months Fed.

**Excise Tax TBD Maximum:** 500,000 doses Minimum: 100 doses Serogroup B Meningococcal Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 200,000 doses Minimum: 100 doses Meningococcal Conjugate (Groups A, C, Y & W)

**Vaccine:** Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 200,000 doses Minimum: 100 doses Pneumococcal Conjugate (PCV)

**Vaccine:** Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 500,000 doses Minimum: 100 doses Pneumococcal Polysaccharide Vaccine: Min. Shelf Life 12 months Fed.

**Excise Tax N/A Maximum:** 500,000 doses Minimum: 100 doses Tetanus and Diptheria Toxoids Vaccine for Adults: Min. Shelf Life 12 months Fed. Excise Tax $1.50 per dose Maximum: 100,000 doses Minimum: 100 doses Tetanus, Reduced Diptheria Toxoid & Acellular Pertusis (TdaP)

**Vaccine:** Min. Shelf Life 12 months Fed. Excise Tax $2.25 per dose Maximum: 850,000 doses Minimum: 100 doses Varicella Vaccine: Min. Shelf Life 12 months Fed. Excise Tax $0.75 per dose Maximum: 150,000 doses Minimum: 10 doses

## Award on USAspending

- Recipient: Bavarian Nordic, Inc. (UEI LA6TFGKSSFC1)
- Contract: 75D30124D19078
- Obligated: $918,000.00
- Competition: Full and Open Competition, 8 offers received
- Link: solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30124D19078_7523/

- Recipient: Dynavax Technologies Corporation (UEI JA7GSG397PL1)
- Contract: 75D30124D19079
- Obligated: $3,923,889.30
- Competition: Full and Open Competition, 8 offers received
- Link: solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30124D19079_7523/

- Recipient: Glaxosmithkline, LLC (UEI FRHTPHMZMX47)
- Contract: 75D30124D19080
- Obligated: $13,152,248.21
- Competition: Full and Open Competition, 8 offers received
- Link: solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30124D19080_7523/

- Recipient: Merck Sharp & Dohme LLC (UEI FCFDA78HKKG2)
- Contract: 75D30124D19081
- Obligated: $13,253,480.77
- Competition: Full and Open Competition, 8 offers received
- Link: solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30124D19081_7523/

- Recipient: Pfizer Inc. (UEI MHBQULRMEEJ5)
- Contract: 75D30124D19082
- Obligated: $3,298,698.20
- Competition: Full and Open Competition, 8 offers received
- Link: solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30124D19082_7523/

- Recipient: Sanofi Vaccines US Inc. (UEI NCXBGGQ8YTU9)
- Contract: 75D30124D19083
- Obligated: $2,368,734.03
- Competition: Full and Open Competition, 8 offers received
- Link: solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30124D19083_7523/

- Recipient: Vbi Vaccines (Delaware) Inc. (UEI FKYXJCJ2BKC3)
- Contract: 75D30124D19084
- Obligated: $0.00
- Competition: Full and Open Competition, 8 offers received
- Link: solicitation number 75D30124R72943 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75D30124D19084_7523/


## Publications

- March 25, 2024: Combined synopsis and solicitation, due April 5, 2024 at 4:00 PM EDT. Notice 16dffe4af6cf4d94a4149881f2051ce1. https://sam.gov/workspace/contract/opp/16dffe4af6cf4d94a4149881f2051ce1/view
- March 29, 2024: Combined synopsis and solicitation, due April 5, 2024 at 4:00 PM EDT. Notice 57e0e2e32c8b43e7ac61952adb35c4fc. https://sam.gov/workspace/contract/opp/57e0e2e32c8b43e7ac61952adb35c4fc/view

## Points of contact

- William O'Bryan, rvq0@cdc.gov

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75d30124r72943.